FDA Approval and Specific Indications for Use The FDA approval for Ozempic was granted in 2017, and it was created with the primary goal of treating type 2 diabetes
Importantly, hemodynamic effects - modest reductions in heart rate (+2-4 bpm) and blood pressure decreases - are generally well tolerated and beneficial in this population
Lilly's Phase 3 TRIUMPH program targets a mid-2025 NDA submission, placing FDA approval most realistically in mid-to-late 2026 under a standard review
These medicines help lower blood sugar, reduce appetite, and often support weight loss
For women with PCOS specifically, monitoring hormonal changes alongside weight loss is valuable
Adene Sanchez/E+ via Getty Image Patient education tips for GLP-1, weight loss drug treatment Obesity treatment is not a one-and-done process